Poly Medicure
NSE: POLYMED · ISIN INE205C01021 · Healthcare
₹1,602.90+4.50 (+0.28%)
Monday 9 November, 12:57 IST. Delayed. Source: Yahoo Finance.
Price chart
₹1,602.90 +4.50 (+0.28%) today
The day
- Previous close
- ₹1,598.40
- Open
- ₹1,597.00
- Day high
- ₹1,607.80
- Day low
- ₹1,578.10
Listed on NSE since 7 December 2011.
Key numbers
- Market value
- ₹16,343 Cr
- P/E (trailing)
- 51.40
- EPS (trailing)
- ₹31.37
- Price to book
- 5.26
- Dividend yield
- 0.22%
- Return on equity
- 10.1%
- Debt to equity
- 0.12
- Profit margin
- 15.1%
- Volume today
- 16,260
- Average volume
- 1.50 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹1,108.66 Cr | ₹179.28 Cr |
| FY24 | ₹1,365.69 Cr | ₹258.26 Cr |
| FY25 | ₹1,655.02 Cr | ₹338.56 Cr |
| FY26 | ₹1,859.48 Cr | ₹322.14 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹581 Cr | ₹95 Cr | +3.6% |
| Q1 FY27Apr–Jun 2026 | ₹525 Cr | ₹86 Cr | −7.6% |
| Q4 FY26Jan–Mar 2026Audited | ₹535 Cr | ₹66 Cr | −27.8% |
| Q3 FY26Oct–Dec 2025 | ₹494 Cr | ₹71 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹444 Cr | ₹92 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹403 Cr | ₹93 Cr | – |
Source: Poly Medicure’s results filed with NSE, consolidated (the whole group). Net profit is the share of Poly Medicure’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹1,460 Cr | ₹1,346 Cr |
| Investments | ₹731 Cr | ₹740 Cr |
| Inventories | ₹512 Cr | ₹434 Cr |
| Owed by customers | ₹559 Cr | ₹531 Cr |
| Cash and equivalents | ₹58 Cr | ₹51 Cr |
| Total assets | ₹4,155 Cr | ₹3,919 Cr |
| Borrowings | ₹386 Cr | ₹342 Cr |
| Total liabilities | ₹848 Cr | ₹769 Cr |
| Shareholders’ equity | ₹3,265 Cr | ₹3,106 Cr |
Source: Poly Medicure’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Poly Medicure
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA balloon dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, including blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, and foley balloon and urine drainage catheters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.
- Industry
- Medical Instruments & Supplies
- Based in
- New Delhi
- Employees
- 2,614
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Poly Medicure in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 3.50 Per Share
Dividend · ex-date 28 August 2026 · record date 29 August 2026
- Dividend - Rs 3.50 Per Share
Dividend · ex-date 18 September 2025
- Annual General Meeting/Dividend - Rs 3 Per Share
Dividend · ex-date 19 September 2024
- Annual General Meeting/Dividend - Rs 3 Per Share
Dividend · ex-date 21 September 2023
- Annual General Meeting/Dividend - Rs 2.50 Per Share
Dividend · ex-date 16 September 2022
- Dividend - Rs 2.50 Per Share
Dividend · ex-date 16 September 2021 · record date 17 September 2021
- Annual General Meeting
Action · ex-date 16 September 2021
- Annual General Meeting
Action · ex-date 21 September 2020
Source: NSE. Latest first, 8 of 20.
Information only, not investment advice. Prices are delayed.